TGTX
TG THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
TG THERAPEUTICS INC (TGTX) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$127.61M; the largest are Renaissance Technologies, Ken Griffin, Ray Dalio. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 3 added, 2 trimmed. 6 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders74 also report options
Congress trades6
Price$56.19vs quarter-end+2.28%
Sectors0
This quarter's moves
Top holderNew2
Added3
Trimmed / sold2
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $20.97M— of portfolio381,7002026 Q2
Value $17.68M— of portfolio321,8002026 Q2
Value $5.26M— of portfolio95,8002026 Q2
Value $4.00M— of portfolio72,8002026 Q2
Value $500.0K— of portfolio9,1002026 Q2
Value $351.6K— of portfolio6,4002026 Q2
Value $351.6K— of portfolio6,4002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $20.97M | — | — |
| Ken GriffinPUT | $17.68M | — | — |
| Steven CohenCALL | $5.26M | — | — |
| Paul Tudor JonesPUT | $4.00M | — | — |
| Izzy EnglanderCALL | $500.0K | — | — |
| Paul Tudor JonesCALL | $351.6K | — | — |
| Steven CohenPUT | $351.6K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.